Literature DB >> 1555113

Treatment of peracute and acute mastitis.

G Ziv1.   

Abstract

This article discusses the cause and pathophysiology of peracute and acute mastitis. The pharmaceutic and pharmacologic properties of potential therapeutic agents, the interaction between the cow and the drug, and some practical aspects of using these drugs are reviewed.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1555113     DOI： 10.1016/s0749-0720(15)30757-x

Source DB:  PubMed          Journal:  Vet Clin North Am Food Anim Pract        ISSN： 0749-0720            Impact factor:   3.357


  4 in total

1.  Mutations in lipopolysaccharide-binding protein (LBP) gene change the susceptibility to clinical mastitis in Chinese Holstein.

Authors:  Jienan Cheng; Jun Li; Wenxin Zhang; Yafei Cai; Genlin Wang
Journal:  Mol Biol Rep       Date:  2012-06-26       Impact factor: 2.316

2.  Acute coliform mastitis in a dairy cow.

Authors:  C Dunn
Journal:  Can Vet J       Date:  1994-05       Impact factor: 1.008

3.  Functional characterization of bovine TIRAP and MyD88 in mediating bacterial lipopolysaccharide-induced endothelial NF-kappaB activation and apoptosis.

Authors:  Elizabeth A Cates; Erin E Connor; David M Mosser; Douglas D Bannerman
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2008-08-28       Impact factor: 2.268

4.  Norfloxacin nicotinate in the treatment of Pseudomonas aeruginosa infection in the genital tract of a bull.

Authors:  S Marcus; M Bernstein; G Ziv; A Glickman; M Gipps
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.